Cogent Biosciences (COGT) Consolidated Net Income: 2017-2020
Historic Consolidated Net Income for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$11.4 million.
- Cogent Biosciences' Consolidated Net Income fell 594.78% to -$11.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$82.1 million, marking a year-over-year decrease of 157.14%. This contributed to the annual value of -$82.1 million for FY2020, which is 157.14% down from last year.
- Cogent Biosciences' Consolidated Net Income amounted to -$11.4 million in Q4 2020, which was up 80.09% from -$57.2 million recorded in Q3 2020.
- Cogent Biosciences' 5-year Consolidated Net Income high stood at $2.3 million for Q4 2019, and its period low was -$57.2 million during Q3 2020.
- Over the past 3 years, Cogent Biosciences' median Consolidated Net Income value was -$9.7 million (recorded in 2018), while the average stood at -$12.4 million.
- As far as peak fluctuations go, Cogent Biosciences' Consolidated Net Income spiked by 126.77% in 2019, and later crashed by 594.78% in 2020.
- Cogent Biosciences' Consolidated Net Income (Quarterly) stood at -$6.8 million in 2017, then fell by 26.77% to -$8.6 million in 2018, then spiked by 126.77% to $2.3 million in 2019, then crashed by 594.78% to -$11.4 million in 2020.
- Its Consolidated Net Income stands at -$11.4 million for Q4 2020, versus -$57.2 million for Q3 2020 and -$7.4 million for Q2 2020.